Avenue Therapeutics, Inc.

Historical 13F Holders

Symbol
ATXI
CUSIP
05360L403
All holders as of
Q4 2024
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 05360L403 since 12/18/2024, largest first.

Filer % of Class Filed
Fortress Biotech, Inc. 13D/A 13.4% 1/6/2026
Event 1/2/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Armistice Capital, LLC 13G/A
4.99% 2/14/2025
Event 12/31/2024
Ikarian Capital, LLC 13G/A
4.1% 2/17/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2024 Q4 8 193 k $385 k
2024 Q3 9 198 k $492 k
2024 Q2 10 116 k $407 k